Yahoo Web Search

Search results

1. • 

     Why Obstetric, Autoimmune History Matter for Women's CV Risk

     Medscape· 4 days ago

     Systemic autoimmune disease is well-recognized as a major risk factor for cardiovascular disease...

2. • 

     UNC Charlotte enters ‘next chapter’ after earning coveted top-tier research status

     Charlotte Observer via Yahoo News· 4 days ago

     “With this, we can potentially help people identify if they have that variant even 10 years before...

3. • 

     Loudoun Therapeutic Riding celebrates 50th anniversary

     Loudoun Times-Mirror· 4 days ago

     As the staff and volunteers at Loudoun Therapeutic Riding reflect on 50 years of service to the...

4. • 

     Earnings call: Vanda Pharmaceuticals reports mixed Q1 results, plans growth

     Investing.com· 4 days ago

     Vanda (NASDAQ: VNDA ) Pharmaceuticals Inc. (VNDA) discussed its performance in the first quarter of...

5. • 

     Better Health Care Newsletter - May 2024 | JD Supra

     JD Supra· 6 days ago

     Federal officials have capped the cost of insulin at $35 a month. For now, that gives relief only to patients 65 and older covered by Medicare. Big...

6. • Celebrity News | Entertainment News | TMZ.com

     TMZ· 2 days ago

     Articles - December, 2020 Famous Dex Named Suspect in Domestic Violence Case, SWAT Visits His Home Selena Gomez Kidney Jokes Removed from 'Saved By The Bell' Reboot Stilwell in 'A League Of Their Own' 'Memba Him?!

7. • NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating...

     NBC 17 Raleigh· 5 days ago

     NeuroSense Therapeutics Ltd. (Nasdaq: NRSN) ("NeuroSense"), a company developing novel treatments for severe neurodegenerative diseases, announces new analyses from its Phase 2b PARADIGM clinical ...

8. • 

     FDA considers updating blood donation guidelines to keep nation’s supply safe from malaria

     WKBT La Crosse· 3 days ago

     Malaria is not considered a big threat to the US blood supply like it is in some other countries. As...

9. • Celltrion USA's adalimumab-aaty biosimilar to HUMIRA® now available at low wholesale acquisition...

     KOLR - KSFX Ozarks· 3 days ago

     Celltrion USA announced today that adalimumab-aaty, the company's high-concentration (100 mg/mL) and citrate-free formulation biosimilar to HUMIRA ® (adalimumab), is now available at a low wholesale ...

10. • Investigational Drugs for Chronic Inflammatory Demyelinating Polyneuropathy

      MedPage Today· 5 days ago

      Investigational therapies may soon change the treatment landscape for chronic inflammatory demyelinating polyneuropathy (CIDP). "Despite the fact that we have some good standard-of-care therapies ...